What is the size of CDMO market in India | Insights, Trends & Growth Analysis 2025

What is the growth rate of the India CDMO Market?

The primary contributors of this growth are the growing outsourcing of pharmaceutical development and manufacturing services, the transition in supply chains to regions with cost advantages, and the rising demand for complex biologics, biosimilars, and advanced therapeutics that require specialized contract services.

Growth Factors for India CDMO Industry

• Liberal increase in the outsourcing of drug development and manufacturing from pharmaceutical companies.
• Firms relocating supply chains to regions of lower cost bases and some level of skilled labour.
• Rise in demand for biologics, biosimilars, and advanced therapy modalities.
• Improvement in manufacturing capabilities and compliance with regulatory framework in the region.
• Government initiatives to support domestic pharmaceutical services and reduce dependence on imports.

India CDMO Market Trends

The India CDMO Market is showing multiple trends as it matures as an outsourcing area and service model for pharmaceuticals. The trends include a rapidly growing integration of end-to end CDMO services that provide development, clinical stage, and commercial manufacturing services all under one roof. There is a rapid acceleration in investment, ordering, implementation, and ramping quility for single-use bioreactors, cell and gene therapy manufacturing, and fill-finish capacities. Indian CDMOs are investing and forming strategic partnerships with international pharma companies for complex molecules, and improving regulatory status for exporting capabilities.

Emerging Developments in the India CDMO Market

The India CDMO Market is undergoing key developments that highlight its expanding role in the pharmaceutical value chain. Developments include Indian contract manufacturers upgrading facilities to handle advanced therapy medicinal products, high potency active pharmaceutical ingredients and sterile injectables. Several players are expanding manufacturing footprints in southern and western states, establishing dedicated biologics, vaccine and ADC capacities. Collaborative models with global pharma companies for technology transfer and services are gaining traction, enabling Indian CDMOs to enter higher value segments.

List of Leading Companies in the India CDMO Market

Some of the leading companies include:

• Piramal Pharma Solutions
• Jubilant Life Sciences
• Syngene International
• Biocon Biologics
• Aurobindo Pharma (CDMO division)
• Shilpa Medicare
• Sai Life Sciences

Frequently Asked Questions About the Market Study (FAQs):